Peter Anevski - 06 Mar 2023 Form 4 Insider Report for Progyny, Inc. (PGNY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Mar 2023, 15:42:17 UTC
Prior SEC filing
06 Mar 2023
Next SEC filing
10 Mar 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark Livingston, Attorney-in-Fact

Key filing fact

Peter Anevski filed Form 4 for Progyny, Inc. (PGNY) on 08 Mar 2023.

Key facts

  • This page summarizes Peter Anevski's Form 4 filing for Progyny, Inc. (PGNY).
  • 8 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Mar 2023, 15:42.

Change

  • Previous filing in this sequence was filed on 06 Mar 2023.
  • Current net transaction value: -$2,195,648.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGNY transaction

Common Stock

Options Exercise

Transaction value
$126,400
Shares
+32,000
Change %
+14%
Price
$3.95*
Shares after
255,901
Date
06 Mar 2023
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$1,145,920
Shares
-32,000
Change %
-13%
Price
$35.81
Shares after
223,901
Date
06 Mar 2023
Ownership
Direct
Footnotes
F1, F2
PGNY transaction

Common Stock

Sale

Transaction value
$286,480
Shares
-8,000
Change %
-8%
Price
$35.81
Shares after
91,838
Date
06 Mar 2023
Ownership
See footnote
Footnotes
F1, F2, F3
PGNY transaction

Common Stock

Options Exercise

Transaction value
$87,496
Shares
+22,151
Change %
+9.9%
Price
$3.95*
Shares after
246,052
Date
07 Mar 2023
Ownership
Direct
PGNY transaction

Common Stock

Sale

Transaction value
$781,709
Shares
-22,151
Change %
-9%
Price
$35.29
Shares after
223,901
Date
07 Mar 2023
Ownership
Direct
Footnotes
F1, F4
PGNY transaction

Common Stock

Sale

Transaction value
$195,436
Shares
-5,538
Change %
-6%
Price
$35.29
Shares after
86,300
Date
07 Mar 2023
Ownership
See footnote
Footnotes
F1, F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGNY transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-32,000
Change %
-2.8%
Price
$0.000000
Shares after
1,096,515
Date
06 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
32,000
Exercise price
$3.95
Footnotes
F5
PGNY transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
$0
Shares
-22,151
Change %
-2%
Price
$0.000000
Shares after
1,074,364
Date
07 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
22,151
Exercise price
$3.95
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.41 to $36.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Footnote F5

One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .